Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark Cream

Robotics Insights Through Flies' Eyes
Common and clumsy-looking, the blow fly is a true artist of flight. Suddenly changing direction, standing still in the air, spinning lightning-fast around its own axis, and making precise, pinpoint landings - all these maneuvers are simply a matter of course. Extremely quick eyesight helps to keep it from losing orientation as it races to and fro. Still, how does its tiny brain process the multiplicity of images and signals so rapidly and efficiently?
generic viagra online
Ablynx Announces A Novel Preclinical Development Candidate Targeting IL6R
Ablynx [Euronext Brussels: ABLX], a pioneer in the discovery and development of Nanobodies®, a novel class of antibody-derived therapeutic proteins, announced that it has advanced ALX-0061, a new Nanobody®-based therapeutic programme, into preclinical development for the treatment of autoimmune and inflammatory diseases. Purchase zoloft to treat depression.
News of the day
New Advances On The Long Road To The Development Of An AIDS Vaccine
AIDS Vaccine Day, May 18, marks the occasion in 1997 when U.S. President Bill Clinton challenged researchers to come up with an AIDS vaccine within the following decade, stating that such a vaccine was the only way to eliminate the threat of AIDS. Twelve years later, the goal of an effective HIV vaccine remains unfulfilled, but the need for one remains urgent. AIDS is the number four killer in the world and number one in sub-Saharan Africa. Despite education and prevention campaigns, every day 7,500 people become infected with HIV. Antiretroviral drugs can prolong the lives of those who are infected, but they are not cures, and because of their cost and logistical difficulties, they reach only a minority of those who need them. And for every two individuals who go on antiretroviral treatment, five become HIV infected. As with any major viral pandemic, a vaccine remains the best hope of ending, and not just mitigating, AIDS.
Cardiovascular

Victorian Invention A Watchful Approach To Parkinson's

Victoria, Australia researchers have developed a wristwatch that continuously monitors the health status of people with Parkinson"s disease to help doctors manage their treatment, Victorian Minister for Innovation Gavin Jennings said today. The wristwatch, which is still at the prototype stage, was introduced onto the world market by Mr. Jennings at the 2009 BIO International Convention in Atlanta, USA. It is designed to assist doctors treating people with Parkinson"s disease by recording their symptoms throughout the day and in the longer term will assist researchers in the development of new drugs for the disease. "The Brumby Government is taking action to promote innovative projects in Victoria and this is an excellent example of how Victorian scientists are moving from basic research into developing products that will clearly benefit patients and their families," Mr. Jennings said. "The right dosage and correct timing of dosing has an enormous impact on the wellbeing of a person with Parkinson"s disease. Currently neurologists can only check dosage and timing by observing the patient during consultations, which may be at 6-8 week intervals. "What this clever device does is provide the physician with an objective measurement of how a patient"s symptoms have changed over time. It is the first of its kind and will provide physicians with information about the effectiveness of medications and guide them in adjusting the timing of medications." The wristwatch (patent pending) has been developed by a team led by Professor Mal Horne and Dr. Rob Griffiths at the Florey Neuroscience Institutes in Melbourne. Mr. Jennings said the device would assist in the development of drugs for Parkinson"s disease which was hampered by an inability to accurately assess whether the treatment is effective. The next stage of development for the wristwatch - to prepare it for commercial sale - is being funded by Melbourne"s Medical Research Commercialisation Fund. The MRCF is a collaborative venture fund established with support from the Victorian and NSW Governments. Dr. Chris Nave, Principal Executive of the MRCF, said the fund had invested an initial $490,000 in Global Kinetics Corporation, a spinout company from the Melbourne-based Florey Neuroscience Institutes to enable researchers to further refine the watch and complete pivotal clinical trials. "We are very pleased to be involved in taking this simple, yet effective, device to its next stage," said Mr. Nave. Parkinson"s disease is a degenerative disorder of the brain that often affects body movements and speech. About 80,000 people are living with Parkinson"s in Australia with one in five people with Parkinson"s diagnosed before the age of 50. In the USA, the disease affects up to two percent of the population and is the most common neurodegenerative movement disorder. Victorian Invention


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009